Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Potassium guaiacolsulfonate hemihydrate

Potassium guaiacolsulfonate hemihydrate

Catalog No.GC39742

Potassium guaiacolsulfonate hemihydrate is an orally active expectorant used for acute respiratory tract infections.

Products are for research use only. Not for human use. We do not sell to patients.

Potassium guaiacolsulfonate hemihydrate Chemical Structure

Cas No.: 78247-49-1

Size Price Stock Qty
10mM (in 1mL DMSO)
$144.00
In stock
25mg
$131.00
In stock
50mg
$203.00
In stock
100mg
$331.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Potassium guaiacolsulfonate hemihydrate is an orally active expectorant used for acute respiratory tract infections. Potassium guaiacolsulfonate hemihydrate helps loosen mucus and used for a cough caused by the common cold, infections or allergies in combination with other drugs[1][2].

[1]. Thi Huong Hoa Le, et al. Development and Validation of an HPLC Method for Simultaneous Assay of Potassium Guaiacolsulfonate and Sodium Benzoate in Pediatric Oral Powder. J Anal Methods Chem. 2019 Mar 7;2019:6143061. [2]. Ozlem Aksu DÖnmez, et al. Simultaneous Determination of Potassium Guaiacolsulfonate, Guaifenesin, Diphenhydramine HCl and Carbetapentane Citrate in Syrups by Using HPLC-DAD Coupled With Partial Least Squares Multivariate Calibration. Talanta. 2011 Feb 15;83(5):1601-5.

Reviews

Review for Potassium guaiacolsulfonate hemihydrate

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Potassium guaiacolsulfonate hemihydrate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.